Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Nanoco Group

    MCap

    GBP26m

    Last close

    GBP0.13

    ▲ 0.60 (4.88%)

    Cobra Resources

    MCap

    GBP18m

    Last close

    GBP0.02

    ▲ 0.00 (0.00%)

    MoneyHero

    MCap

    USD31m

    Last close

    USD1.05

    ▲ 0.02 (1.94%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Cereno Scientific (OMX: CRNO-B)

Last close As at 05/07/2025

SEK9.55

▲ −0.56 (−5.50%)

Market capitalisation

SEK2,838m

Based in Sweden, Cereno Scientific is focused on the development of innovative, effective and safe treatments for people with rare cardiovascular and pulmonary diseases. Lead asset CS1, an HDAC inhibitor that acts as an epigenetic modulator, is currently being investigated in a Phase II clinical trial for the treatment of PAH.

Latest Insights

View More

Healthcare | edison tv

Cereno Scientific – executive interview

Healthcare | Comment

Cereno Scientific (STO: CRNO-B) enters the FN25 Index

Healthcare | Flash

Cereno Scientific — Improved liquidity with latest debt financing

Healthcare | Flash

Cereno Scientific — Four-month EAP data support CS1 plans
Visit Website

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Eva Jagenheim

    CFO

  • Joakim Söderström

    Chairman

  • Sten Sörensen

    CEO